Company profile for Bristol-Myers Squibb Company (BMY) with a description, list of executives, contact details and other key facts. ... Stock Analysis Pro. Watchlist. Collapse. Bristol-Myers Squibb Company (BMY) NYSE: BMY · IEX Real-Time Price · USD. Add to Watchlist 50.62 +0.76 (1.51%) Feb 21, 2024, 3:21 PM EST - Market …Bristol-Myers Squibb's most recent quarterly dividend payment of $0.60 per share was made to shareholders on Thursday, February 1, 2024. When was Bristol-Myers Squibb's most recent ex-dividend date? Bristol-Myers Squibb's most recent ex-dividend date was Thursday, January 4, 2024. Is Bristol-Myers Squibb's dividend growing?Oct 5, 2020 ... ... shares of MyoKardia's common stock for $225.00 per share in cash. ... price of $225.00 per share. Bristol Myers Squibb expects to finance the ...Dividend History Summary. Bristol Myers Squibb (BMY) announced on December 6, 2023 that shareholders of record as of January 4, 2024 would receive a dividend of $0.60 per share on February 1, 2024 ...Compared to its fair value of $88 a share, Bristol-Myers is obscenely undervalued at the current $57 share price. The stock is priced 35% below its fair value of $88 and could have a 54% capital ...3 days ago · 19 analysts have issued 12-month price targets for Bristol-Myers Squibb's shares. Their BMY share price targets range from $50.00 to $85.00. On average, they expect the company's share price to reach $61.17 in the next year. This suggests a possible upside of 19.2% from the stock's current price. On average, Wall Street analysts predict. that Bristol Myers Squibb Co's share price could reach $60.40 by Feb 6, 2025. The average Bristol Myers Squibb Co stock price prediction forecasts a potential upside of 18.64% from …Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. Feb 16, 2024 · Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Under the terms of the merger agreement, Bristol Myers Squibb through a subsidiary will acquire all of the outstanding shares of Mirati common stock at a price of $58.00 per share in cash representing a 52% premium to the 30-day VWAP as of the unaffected October 4, 2023 close, for a total equity value of $4.8 billion corresponding to …The 53 analysts offering price forecasts for Bristol-Myers Squibb have a median target of 69.94, with a high estimate of 95.00 and a low estimate of 50.00. The …PRINCETON, N.J., February 15, 2024--Bristol Myers Squibb Prices $13 Billion of Senior Unsecured Notes. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Bristol Myers Squibb has gathered orders exceeding $85 billion for its corporate bond sale to help finance its acquisitions of Karuna Therapeutics Inc. and …BMY Dividend Information. BMY has an annual dividend of $2.40 per share, with a forward yield of 4.68%. The dividend is paid every three months and the last ex-dividend date was Jan 4, 2024. Dividend Yield. 4.68%. Annual Dividend. $2.40. Ex-Dividend Date. Jan 4, 2024.The 53 analysts offering price forecasts for Bristol-Myers Squibb have a median target of 69.94, with a high estimate of 95.00 and a low estimate of 50.00. The …Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment ... The stock isn't nearly as risky as its low valuation suggests.Feb 15, 2024 · With Bristol Myers Squibb Co stock trading at $49.44 per share, the total value of Bristol Myers Squibb Co stock (market capitalization) is $99.98B. Bristol Myers Squibb Co stock was originally listed at a price of $47.32 in Dec 31, 1997. If you had invested in Bristol Myers Squibb Co stock at $47.32, your return over the last 26 years would ... Feb 16, 2024 · Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Get the latest Bristol-Myers Squibb Co (BMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Jun 3, 2022 ... ... shares of Turning Point Therapeutics' common stock at a price of $76.00 per share in an all-cash transaction for a total consideration of ...Bristol Myers Squibb Co. Dividend Stock News and Updates. Dec. 07, 2023 DIVIDEND RATE INCREASE: Bristol Myers Squibb Co. (NYSE: BMY) on 12-07-2023 increased dividend rate > 3% from $2.28 to $2.40. ... 2024 ZOM STOCK PRICE DECREASE: Zomedica Corp on 02-17-2024 decreased stock price > 10% from $0.14 to $0.12. Read …View the latest Bristol Myers Squibb Co. (BMY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Bristol-Myers Squibb Company ; Prev. Close. 51.33 ; Low. 50.73 ; 52wk Low. 47.58 ; Market Cap. 104.47b ; Total Shares. 2.02b.Research Bristol-Myers Squibb's (NYSE:BMY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener. Stocks / Pharmaceuticals & Biotech; Bristol-Myers Squibb NYSE:BMY Stock Report. Last Price. US$51.33. …BRISTOL-MYERS SQUIBB CO. BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Investors with a lot of money to spend have taken a bearish stance on Bristol-Myers Squibb BMY. ... In the last month, 2 experts released ratings on this stock with an average target price of $52.5.Real-time Price Updates for Bristol-Myers Squibb Company (BMY-N), along with buy or sell indicators, analysis, charts, historical performance, news and moreUnder the terms of the merger agreement, Bristol Myers Squibb through a subsidiary will acquire all of the outstanding shares of Mirati common stock at a price of $58.00 per share in cash representing a 52% premium to the 30-day VWAP as of the unaffected October 4, 2023 close, for a total equity value of $4.8 billion corresponding to …Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 13.2. Bristol-Myers Squibb Co’s trailing 12-month revenue is $45.0 billion with a 17.8% net profit margin. Year-over-year quarterly sales growth most recently was 0.6%. Analysts expect adjusted earnings to reach $6.850 per share for the current fiscal year. ... Stock information > · Financial reporting > · Analyst coverage > · Events and ... costs, expenses, gains and losses and other specified items. Rec...Under the terms of the merger agreement, Bristol Myers Squibb will promptly commence a tender offer to acquire all of the outstanding shares of Turning Point Therapeutics’ common stock at a price of $76.00 per share in an all-cash transaction for a total consideration of $4.1 billion in equity value.Detailed statistics for Bristol-Myers Squibb Company (BMY) stock, including valuation metrics, financial numbers, share information and more. ... The stock price has ... Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $51 From $58, Maintains Equalweight Rating Feb. 06: MT Redburn Downgrades Bristol-Myers Squibb …Bristol Myers Squibb's disappointing medium-term guidance on its new product portfolio justified the valuation de-rating as investors assessed the increased execution risks. Accordingly, BMS ...Additionally, according to Portfolio Insight *, BMY’s five-year dividend growth rate is about 7.3%, which is excellent. The 10-year dividend growth rate is a little lower, at ~2.6%. It is noteworthy that Bristol-Myers Squibb stock continued to pay dividends during the most challenging period in the last 100 years.Investors with a lot of money to spend have taken a bearish stance on Bristol-Myers Squibb BMY. ... In the last month, 2 experts released ratings on this stock with …Jan 23, 2024 · PRINCETON, N.J., January 23, 2024--Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc.® ("Mirati"). With the ... Feb 4, 2022 ... ... stock awards in the prior year, and certain incremental and ... price adjustments, acquisition and integration expenses, restructuring costs ...Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene …Bristol Myers Squibb Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time BMY stock price.Research Bristol-Myers Squibb's (NYSE:BMY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...PRINCETON, N.J., February 23, 2024 -- ( BUSINESS WIRE )--Bristol Myers Squibb (NYSE: BMY) today announced that its previously announced tender offer (the …We estimate Bristol Myers Squibb’s Valuation to be $77 per share, reflecting over 45% upside from its current levels of $52. Our forecast is based on a 10x P/E multiple for BMY and expected ...How to buy Bristol Myers Squibb stock: Step-by-step. Bristol Myers Squibb is a public company listed on the New York Stock Exchange under the ticker symbol BMY. It is also an S&P 100 and S&P 500 component, meaning it is among the one hundred largest companies on the stock exchange. To invest in Bristol Myers Squibb, …According to the issued ratings of 19 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 15 hold ratings and 3 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $61.17 with a high price target of $85.00 and a low price target of $50. ...Jun 3, 2022 ... ... shares of Turning Point Therapeutics' common stock at a price of $76.00 per share in an all-cash transaction for a total consideration of ...What this means: Bristol-Myers Squibb Company (BMY) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives BMY a rank of 25. Our methodology considers analysis of the company's financial situation and how it has traded recently. BMY rank of 25 means that it ranks below 75% of stocks.The next Bristol-Myers Squibb Co. dividend is expected to go ex in 2 months and to be paid in 3 months . The previous Bristol-Myers Squibb Co. dividend was 60c and it went ex 1 month ago and it was paid 14 days ago . There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 1.4.Bristol-Myers Squibb’s other top drugs, Eliquis, an anticoagulant, and Opdivo, used for chemotherapy, brought in 21% and 15% more revenue, respectively, for 2022. ... Bristol-Myers Squibb stock ... Stock split history for Bristol-Myers Squibb (BMY) Bristol-Myers Squibb stock (symbol: BMY) underwent a total of 6 stock splits. The most recent stock split occured on August 7th, 2001. One BMY share bought prior to May 31st, 1977 would equal to 33.621320960687 BMY shares today.BRISTOL-MYERS SQUIBB CO. BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Last year's total dividend payments show that Bristol-Myers Squibb has a trailing yield of 3.3% on the current share price of $69.31. Dividends are a major contributor to investment returns for ...Under the terms of the merger agreement, Bristol Myers Squibb will promptly commence a tender offer to acquire all of the outstanding shares of Turning Point Therapeutics’ common stock at a price of $76.00 per share in an all-cash transaction for a total consideration of $4.1 billion in equity value.Bristol Myers Squibb ( NYSE: BMY) priced a public offering of senior unsecured notes in a combined aggregate principal amount of $13B. The notes will be issued in nine tranches, including: $500M ...Information on stock, financials, earnings, subsidiaries, investors, and executives for Bristol-Myers Squibb. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Bristol-Myers Squibb. Use the PitchBook Platform to explore the full profile. ... Bristol …Dividend History Summary. Bristol Myers Squibb (BMY) announced on December 6, 2023 that shareholders of record as of January 4, 2024 would receive a dividend of $0.60 per share on February 1, 2024 ...Bristol Myers Squibb Co. Dividend Stock News and Updates Dec. 07, 2023 DIVIDEND RATE INCREASE: Bristol Myers Squibb Co. (NYSE: BMY) on 12-07-2023 increased dividend rate > 3% from $2.28 to $2.40 Read more... Bristol-Myers Squibb Co Follow Share $51.66 After Hours: $51.60 (0.12%) -0.060 Closed: Feb 23, 7:58:31 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc $27.76 PFE0.76% Gilead... According to 18 analysts, the average rating for BMY stock is "Hold." The 12-month stock price forecast is $60.82, which is an increase of 17.73% from the ...Bristol Myers Squibb (BMY) · (Delayed Data from NYSE) · Quote Overview · Research Reports for BMY · News for BMY · Price and EPS Surprise Chart &...Jun 2, 2023 ... Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and ...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. Bristol-Myers Squibb Company (BMY) NYSE - NYSE Delayed Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 51.66 +0.33 ... Vanguard Total Stock Market Index Fund: 65,550,010: Jun 29, 2023:You can buy and sell Bristol-Myers Squibb (BMY) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... Bristol-Myers Squibb Company's ( ) solid earnings announcement recently didn't do much to the stock …Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable to their trading decisions A total of 25 investors have a majority stake in the company ...Bristol Myers Squibb Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time BMY stock price.Bristol-Myers Squibb Co Follow Share $51.66 After Hours: $51.60 (0.12%) -0.060 Closed: Feb 23, 7:58:31 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc $27.76 PFE0.76% Gilead... View live Bristol-Myers Squibb Company chart to track its stock's price action. Find market predictions, BMY financials and market news. Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc. ® (“Mirati”). With the completion of the acquisition, Mirati shares have ceased trading on the NASDAQ Global Select Market and Mirati is now a wholly owned subsidiary of Bristol Myers Squibb. …Stock Price | Live Quote | Historical Chart. Bristol-Myers Squibb traded at $49.39 this Tuesday January 30th, decreasing $0.48 or 0.96 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb lost 6.39 percent. Over the last 12 months, its price fell by 32.02 percent.The above table shows the analyst BMY forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$49.86 Contact Us U.S. markets open in 5 hours 18 minutes +342.25(+1.95%) +11.50(+0.57%) +0.21(+0.27%) (+0.38%) Bristol-Myers Squibb Company (BMY) NYSE - NYSE Delayed Price. Currency in USD Follow 2W... 1.61%. £67.2B. CELG.RT | Complete Bristol Myers Squibb Co. Rt stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Oct 5, 2020 ... ... shares of MyoKardia's common stock for $225.00 per share in cash. ... price of $225.00 per share. Bristol Myers Squibb expects to finance the ...Bristol-Myers Squibb Co Latest News View All 7 Biotech Stocks Fighting America’s Deadliest Diseases InvestorPlace 3 days ago Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing CNBC 3 days ago 3 Blue-Chip Stocks to Buy at a 52-Week Low in February InvestorPlace 4 days agoBristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene …The above table shows the analyst BMY forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$49.86 Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 13.2. Bristol-Myers Squibb Co’s trailing 12-month revenue is $45.0 billion with a 17.8% net profit margin. Year-over-year quarterly sales growth most recently was 0.6%. Analysts expect adjusted earnings to reach $6.850 per share for the current fiscal year. Bristol-Myers Squibb Co currently has a …Bristol Myers Squibb’s adjusted gross margin declined by 150 bps y-o-y to 76.4% in Q4’23, partly due to product mix. This resulted in the company’s bottom line …Find the latest historical data for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com. View the latest Bristol Myers Squibb Co. (BMY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Contact Us U.S. markets open in 5 hours 18 minutes +342.25(+1.95%) +11.50(+0.57%) +0.21(+0.27%) (+0.38%) Bristol-Myers Squibb Company (BMY) NYSE - NYSE Delayed Price. Currency in USD Follow 2W... You can buy and sell Bristol-Myers Squibb (BMY) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. October 19, 2023 at 10:01 AM · 4 min read. Wall Street expects a year-over-year decline in earnings on lower revenues when Bristol Myers Squibb (BMY) reports results for the quarter ended ...BMY - Bristol Myers Squibb Co. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity. So, based on the above formula, the ROE for Bristol-Myers Squibb is: 29% = US$8.3b ÷ US$29b (Based on the ...Bristol-Myers Squibb Company (BMY) NYSE - NYSE Delayed Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 51.66 +0.33 ... Vanguard Total Stock Market Index Fund: 65,550,010: Jun 29, 2023:
Research Bristol-Myers Squibb's (NYSE:BMY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener. Stocks / Pharmaceuticals & Biotech; Bristol-Myers Squibb NYSE:BMY Stock Report. Last Price. US$51.33. …. Konosuba season 3
Bristol-Myers Squibb Co Follow Share $51.66 After Hours: $51.60 (0.12%) -0.060 Closed: Feb 23, 7:58:31 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc $27.76 PFE0.76% Gilead... We estimate Bristol Myers Squibb’s Valuation to be $77 per share, reflecting over 45% upside from its current levels of $52. Our forecast is based on a 10x P/E multiple for BMY and expected ...The 17 analysts with 12-month price forecasts for BMY stock have an average target of 60.82, with a low estimate of 50 and a high estimate of 84. The average target predicts an increase of 21.98% from the current stock price of 49.86. According to the issued ratings of 19 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 15 hold ratings and 3 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $61.17 with a high price target of $85.00 and a low price target of $50. ...4 days ago · 1.61%. £67.2B. CELG.RT | Complete Bristol Myers Squibb Co. Rt stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View All Top stories. Bristol-Myers Squibb ( BMY - Get Rating) is the poster child for a stock to own during a bear market. First, because it’s in the defensive healthcare industry which doesn’t buckle when the economy is under pressure. Second, the north of 3% dividend yield is a welcome sight when you bank account pays nothing on cash.The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company.Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total …Feb 16, 2024 · Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. We estimate Bristol Myers Squibb’s Valuation to be $65 per share, reflecting about a 30% upside from its current levels of $50. Our forecast is based on a 9x P/E multiple for BMY and expected ...61.04. 9,052,800. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for BMY stock on Yahoo Finance. View daily, weekly or monthly formats back to when Bristol-Myers Squibb Company stock was issued.arrow-down$-0.73 (-1.50%) · Key stats · Price · Fair value · Dividends · News · Financials · Valuation · Profile.Feb 16, 2024 · Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Real time Bristol Myers Squibb (BMY) stock price quote, stock graph, news & analysis. Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. On average, Wall Street analysts predict. that Bristol Myers Squibb Co's share price could reach $60.40 by Feb 6, 2025. The average Bristol Myers Squibb Co stock price prediction forecasts a potential upside of 18.64% from …Get real-time Bristol-Myers Squibb (BMY) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and ...Bristol-Myers Squibb Stock Forecast 2023. In the last five quarters, Bristol-Myers Squibb’s Price Target has fallen from $83.11 to $60.66 - a -27.01% decrease. Twenty-six analysts predict that Bristol-Myers Squibb’s share price will fall in the coming year, reaching $55.00. This would represent a decrease of -9.33%.BRISTOL-MYERS SQUIBB CO. BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals..